Principles of HIV resistance testing and overview of assay performance characteristics

Antiviral Therapy

Volumn 5, Issue 1, 2000, Pages 27-31

  Richman, Douglas D ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; NELFINAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ASSAY; CODON USAGE; CONFERENCE PAPER; DRUG RESISTANCE; DRUG SENSITIVITY; GENE MUTATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; LABORATORY TEST; METHODOLOGY; NONHUMAN; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; STANDARD; VALIDATION PROCESS; VIRUS MUTATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0034017911     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vézinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S & Richman DD. Antiretroviral drug resistance testing in adults with HIV infection. Journal of the American Medical Association 1998; 279:1984-1991.
2. Günthard HF, Wong JK, Havlir DV & Richman DD. Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. AIDS Research in Human Retrovirus 1998; 14:869-876.
3. DeGruttola V, Dix L, D'Aquila R, Holder D, Phillips A, Ait-Khaled M, Baxter J, Clevenbergh P, Hammer S, Harrigan R, Katzenstein D, Lanier R, Miller M, Para M, Yerly S, Zolopa A, Murray T, Patick A, Miller V, Castillo S, Pedneault L & Mellors J. The relationship between base-line HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antiviral Therapy 2000; 5:41-48.
4. Havlir DV, Eastman S, Gamst A & Richman DD. Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. Journal of Virology 1996; 70:7894-7899.
5. Stuyver L, Wyseur A, Rombout A, Louwagie J, Scarcez T, Vernofstede C, Rimland D, Schinazi RF & Rossau R. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrobial Agents and Chemotherapy 1997; 41:284-291.